Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 1;178(6):854-856.
doi: 10.1001/jamainternmed.2018.0776.

Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries

Aaron P Mitchell  1   2   3 , Aaron N Winn  4   5 , Stacie B Dusetzina  6   7
Affiliations

Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries

Aaron P Mitchell et al. JAMA Intern Med. .

Abstract

This study examines the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there are multiple treatment options.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Association Between Receipt of Pharmaceutical Industry Payments in 2013 and Drug Prescribing in 2014, by Individual Drug
A and B, Multivariable logistic regression was used to estimate the association between receipt of manufacturer payments and physicians’ prescribing of that manufacturer’s drug. Each bar represents the market share for a specific drug (the probability of using the drug of interest relative to the other included treatments). Physicians who received payments from the manufacturer of the drug of interest are shown in light blue; physicians who did not are shown in dark blue. Results are adjusted for physician age, region, practice size, prescribing volume, and year of medical school graduation. Sunitinib was given as sunitinib malate; pazopanib as pazopanib hydrochloride; imatinib as imatinib mesylate; and nilotinib as nilotinib hydrochloride monohydrate. aP < .05.
See this image and copyright information in PMC

References

    1. Centers for Medicare & Medicaid Services The facts about Open Payments data. https://openpaymentsdata.cms.gov/summary. Published 2016. Accessed March 4, 2018.
    1. Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS. Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts. JAMA Intern Med. 2016;176(6):763-768. - PubMed
    1. DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122. - PubMed
    1. Perlis RH, Perlis CS. Physician payments from industry are associated with greater Medicare Part D prescribing costs. PLoS One. 2016;11(5):e0155474. - PMC - PubMed
    1. Ratain MJ. Forecasting unanticipated consequences of “The Sunshine Act”: mostly cloudy. J Clin Oncol. 2014;32(22):2293-2295. - PMC - PubMed

Publication types

Substances

LinkOut - more resources